Yasufuku Tomihiko, Shigemura Katsumi, Shirakawa Toshiro, Nakano Yuzo, Tanaka Kazushi, Arakawa Soichi, Kinoshita Shouhiro, Nishimura Kunihiro, Kawabata Masato, Fujisawa Masato
Department of Surgery, Division of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Scand J Infect Dis. 2011 Feb;43(2):83-8. doi: 10.3109/00365548.2010.526632. Epub 2010 Oct 14.
As fluoroquinolone-resistant strains of Escherichia coli emerge, several risk factors for fluoroquinolone resistance have become evident, such as amino acid mutations in the quinolone resistance determining regions (QRDR) of gyrA and parC and previous use of fluoroquinolone. This study investigated risk factors for fluoroquinolone resistance and amino acid mutation in the QRDR in E. coli. We investigated the statistical correlation between each amino acid mutation and resistance to levofloxacin. We examined the minimum inhibitory concentration (MIC) of levofloxacin and the amino acid mutations of gyrA and parC by direct DNA sequence in E. coli clinically isolated from urinary tract infection (UTI) patients. We investigated risk factors for levofloxacin resistance, such as age, sex, and previous use of fluoroquinolone. We found a significant correlation between the number of mutations and resistance to levofloxacin (p < 0.001) and between the presence of underlying urinary tract disease and the presence of mutations (p = 0.004) by multivariate analyses. Three mutations in QRDR were demonstrated to be significantly correlated with levofloxacin resistance. In conclusion, these findings contribute to our understanding of the molecular mechanisms and risk factors for fluoroquinolone resistance.
随着耐氟喹诺酮类大肠杆菌菌株的出现,耐氟喹诺酮的几个危险因素已变得明显,如gyrA和parC喹诺酮耐药决定区(QRDR)中的氨基酸突变以及先前使用过氟喹诺酮。本研究调查了大肠杆菌中氟喹诺酮耐药和QRDR中氨基酸突变的危险因素。我们研究了每种氨基酸突变与左氧氟沙星耐药之间的统计相关性。我们通过对从尿路感染(UTI)患者临床分离的大肠杆菌进行直接DNA测序,检测了左氧氟沙星的最低抑菌浓度(MIC)以及gyrA和parC的氨基酸突变。我们调查了左氧氟沙星耐药的危险因素,如年龄、性别和先前使用氟喹诺酮的情况。通过多变量分析,我们发现突变数量与左氧氟沙星耐药之间存在显著相关性(p < 0.001),以及潜在泌尿系统疾病的存在与突变的存在之间存在显著相关性(p = 0.004)。QRDR中的三个突变被证明与左氧氟沙星耐药显著相关。总之,这些发现有助于我们理解氟喹诺酮耐药的分子机制和危险因素。